Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
9
SHIM Quote, Financials, Valuation and Earnings
Last price:
$1.68
Seasonality move
:
-70.55%
Day range:
$1.63 - $1.77
52-week range:
$1.47 - $7.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.11x
P/B ratio:
49.86x
Volume:
5.3K
Avg. volume:
12.2K
1-year change:
-75%
Market cap:
$58.3M
Revenue:
$480.2M
EPS (TTM):
-$4.31
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $572.7M | $664.2M | $632.8M | $480.2M | |
| Revenue Growth (YoY) | -- | -- | 15.98% | -4.72% | -24.11% | |
| Cost of Revenues | -- | $705.5M | $640.6M | $610.4M | $535.9M | |
| Gross Profit | -- | -$132.8M | $23.5M | $22.4M | -$55.6M | |
| Gross Profit Margin | -- | -23.19% | 3.54% | 3.54% | -11.59% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $77.5M | $60.4M | $61.5M | $64M | |
| Other Inc / (Exp) | -- | $234.7M | $43.7M | $39.5M | -$670K | |
| Operating Expenses | -- | $80.2M | $63.1M | $64.1M | $64M | |
| Operating Income | -- | -$213M | -$39.6M | -$41.8M | -$119.6M | |
| Net Interest Expenses | -- | -- | -- | -- | $5.4M | |
| EBT. Incl. Unusual Items | -- | $21.7M | $4.2M | -$2.3M | -$125.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$24.1M | $1.3M | -- | -$963K | |
| Net Income to Company | -- | $45.8M | $2.9M | -$2.3M | -$124.7M | |
| Minority Interest in Earnings | -- | -$431K | $853K | -$260K | -- | |
| Net Income to Common Excl Extra Items | -- | $45.4M | $3.8M | -$2.5M | -$124.7M | |
| Basic EPS (Cont. Ops) | -- | $1.78 | $0.15 | -$0.11 | -$4.10 | |
| Diluted EPS (Cont. Ops) | -- | $1.78 | $0.15 | -$0.11 | -$4.10 | |
| Weighted Average Basic Share | -- | $25.5M | $25.5M | $22.4M | $30.4M | |
| Weighted Average Diluted Share | -- | $25.5M | $25.5M | $22.4M | $30.4M | |
| EBITDA | -- | -$198M | -$23.6M | -$24.6M | -$105.2M | |
| EBIT | -- | -$213M | -$39.6M | -$41.8M | -$120.3M | |
| Revenue (Reported) | -- | $572.7M | $664.2M | $632.8M | $480.2M | |
| Operating Income (Reported) | -- | -$213M | -$39.6M | -$41.8M | -$119.6M | |
| Operating Income (Adjusted) | -- | -$213M | -$39.6M | -$41.8M | -$120.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $186.2M | $138.1M | $103.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -25.86% | -25% | |
| Cost of Revenues | -- | -- | $181.2M | $138.5M | $124.4M | |
| Gross Profit | -- | -- | $5M | -$405K | -$20.8M | |
| Gross Profit Margin | -- | -- | 2.68% | -0.29% | -20.13% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $16.6M | $13.7M | $16.1M | |
| Other Inc / (Exp) | -- | -- | -$5.8M | -$1.8M | -$1.4M | |
| Operating Expenses | -- | -- | $17.3M | $16.3M | $16.1M | |
| Operating Income | -- | -- | -$12.3M | -$16.7M | -$36.9M | |
| Net Interest Expenses | -- | -- | -- | -- | $1.1M | |
| EBT. Incl. Unusual Items | -- | -- | -$18M | -$17.5M | -$39.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $17K | -- | -$963K | |
| Net Income to Company | -- | -- | -- | -$17.5M | -$38.5M | |
| Minority Interest in Earnings | -- | -- | $147K | -$3K | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$17.9M | -$17.5M | -$38.5M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.70 | -$0.69 | -$1.13 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.70 | -$0.69 | -$1.13 | |
| Weighted Average Basic Share | -- | -- | $25.5M | $25.5M | $34M | |
| Weighted Average Diluted Share | -- | -- | $25.5M | $25.5M | $34M | |
| EBITDA | -- | -- | -$8.1M | -$54M | -$34.9M | |
| EBIT | -- | -- | -$12.3M | -$58M | -$38.4M | |
| Revenue (Reported) | -- | -- | $186.2M | $138.1M | $103.6M | |
| Operating Income (Reported) | -- | -- | -$12.3M | -$16.7M | -$36.9M | |
| Operating Income (Adjusted) | -- | -- | -$12.3M | -$58M | -$38.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $664.2M | $632.8M | $480.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $610.4M | $535.9M | |
| Gross Profit | -- | -- | -- | $22.4M | -$55.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $60.2M | $62.7M | |
| Other Inc / (Exp) | -- | -- | $14.5M | $39.4M | -$1.6M | |
| Operating Expenses | -- | -- | -- | $64.1M | $64M | |
| Operating Income | -- | -- | -- | -$41.8M | -$119.6M | |
| Net Interest Expenses | -- | -- | -- | $988K | $4.5M | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$2.3M | -$125.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -$963K | |
| Net Income to Company | -- | -- | -- | -$2.3M | -$124.7M | |
| Minority Interest in Earnings | -- | -- | $249K | -$260K | $1K | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$2.5M | -$124.7M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$0.10 | -$4.31 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.10 | -$4.31 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -$25.3M | -$104.7M | |
| EBIT | -- | -- | -- | -$42.4M | -$119.9M | |
| Revenue (Reported) | -- | -- | $664.2M | $632.8M | $480.2M | |
| Operating Income (Reported) | -- | -- | -- | -$41.8M | -$119.6M | |
| Operating Income (Adjusted) | -- | -- | -- | -$42.4M | -$119.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $370.6M | $632.8M | $480.2M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $352.4M | $610.4M | $535.9M | -- | |
| Gross Profit | -- | $18.1M | $22.4M | -$55.7M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $31.5M | $60.2M | $62.7M | -- | |
| Other Inc / (Exp) | -- | $14.5M | $39.4M | -$1.6M | -- | |
| Operating Expenses | -- | $32.8M | $64.1M | $64M | -- | |
| Operating Income | -- | -$14.7M | -$41.8M | -$119.6M | -- | |
| Net Interest Expenses | -- | -- | $988K | $4.5M | -- | |
| EBT. Incl. Unusual Items | -- | -$182K | -$2.3M | -$125.7M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $17K | -- | -$963K | -- | |
| Net Income to Company | -- | -- | -$2.3M | -$124.7M | -- | |
| Minority Interest in Earnings | -- | $249K | -$260K | $1K | -- | |
| Net Income to Common Excl Extra Items | -- | $50K | -$2.5M | -$124.7M | -- | |
| Basic EPS (Cont. Ops) | -- | $0.00 | -$0.10 | -$4.31 | -- | |
| Diluted EPS (Cont. Ops) | -- | $0.00 | -$0.10 | -$4.31 | -- | |
| Weighted Average Basic Share | -- | $51M | $102M | $121.4M | -- | |
| Weighted Average Diluted Share | -- | $51M | $102M | $121.4M | -- | |
| EBITDA | -- | -$6.6M | -$25.3M | -$104.7M | -- | |
| EBIT | -- | -$14.7M | -$42.4M | -$119.9M | -- | |
| Revenue (Reported) | -- | $370.6M | $632.8M | $480.2M | -- | |
| Operating Income (Reported) | -- | -$14.7M | -$41.8M | -$119.6M | -- | |
| Operating Income (Adjusted) | -- | -$14.7M | -$42.4M | -$119.9M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $73.2M | $77.8M | $62.9M | $33.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $130M | $56.4M | $54.2M | $43M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $17.4M | $14.1M | $13.4M | $15.6M | |
| Total Current Assets | -- | $255.2M | $233.5M | $257.5M | $141M | |
| Property Plant And Equipment | -- | $84.4M | $77.9M | $70.2M | $43.4M | |
| Long-Term Investments | -- | $17.7M | $17.4M | $21.3M | $19M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | $14.7M | $12M | $9.2M | -- | |
| Other Long-Term Assets | -- | $1.1M | $3.1M | $2.9M | $300K | |
| Total Assets | -- | $492M | $446.8M | $426.7M | $233.9M | |
| Accounts Payable | -- | $57.1M | $67.5M | $81.6M | $46.5M | |
| Accrued Expenses | -- | $61.4M | $97M | $60.8M | $67.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | $12.3M | $12.7M | $13.1M | $13.8M | |
| Total Current Liabilities | -- | $388.7M | $340.9M | $271.3M | $230.3M | |
| Long-Term Debt | -- | -- | -- | $29.6M | $9.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $445M | $395.2M | $356.2M | $268.5M | |
| Common Stock | -- | $80K | $219K | $255K | $343K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | $46.6M | $52.6M | $71.2M | -$34.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $433K | -$1M | -$747K | -$159K | |
| Total Equity | -- | $47M | $51.6M | $70.5M | -$34.7M | |
| Total Liabilities and Equity | -- | $492M | $446.8M | $426.7M | $233.9M | |
| Cash and Short Terms | -- | $73.2M | $77.8M | $62.9M | $33.7M | |
| Total Debt | -- | -- | -- | $29.6M | $9.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $77.8M | $62.9M | $33.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $56.4M | $54.2M | $43M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $14.1M | $13.4M | $15.6M | |
| Total Current Assets | -- | -- | $233.5M | $257.5M | $141M | |
| Property Plant And Equipment | -- | -- | $77.9M | $70.2M | $43.4M | |
| Long-Term Investments | -- | -- | $17.4M | $21.3M | $19M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $12M | $9.2M | -- | |
| Other Long-Term Assets | -- | -- | $3.1M | $2.9M | $300K | |
| Total Assets | -- | -- | $446.8M | $426.7M | $233.9M | |
| Accounts Payable | -- | -- | $67.5M | $81.6M | $46.5M | |
| Accrued Expenses | -- | -- | $97M | $60.8M | $67.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | $12.7M | $13.1M | $13.8M | |
| Total Current Liabilities | -- | -- | $340.9M | $271.3M | $230.3M | |
| Long-Term Debt | -- | -- | -- | $29.6M | $9.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $395.2M | $356.2M | $268.5M | |
| Common Stock | -- | -- | $219K | $255K | $343K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -$1M | -$747K | -$159K | |
| Total Equity | -- | -- | $51.6M | $70.5M | -$34.7M | |
| Total Liabilities and Equity | -- | -- | $446.8M | $426.7M | $233.9M | |
| Cash and Short Terms | -- | -- | $77.8M | $62.9M | $33.7M | |
| Total Debt | -- | -- | -- | $29.6M | $9.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $45.8M | $2.9M | -$2.3M | -$124.7M | |
| Depreciation & Amoritzation | -- | $14.9M | $16M | $17.1M | $15.1M | |
| Stock-Based Compensation | -- | $1.2M | $2.3M | $2.1M | $6.1M | |
| Change in Accounts Receivable | -- | -$7.7M | $1.9M | -$6.8M | $115.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$54M | -$3.1M | -$88.1M | -$21.3M | |
| Capital Expenditures | -- | $2.9M | $10.4M | $7M | $10.5M | |
| Cash Acquisitions | -- | $137.4M | $12.9M | -$6.9M | -$6.3M | |
| Cash From Investing | -- | $136.2M | $4.2M | $22.1M | $15M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $9.5M | |
| Long-Term Debt Repaid | -- | -$294K | -$303K | -$303K | -$29.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$628K | -$6.8M | -$1.5M | |
| Cash From Financing | -- | -$294K | -$931K | $47.9M | -$21.9M | |
| Beginning Cash (CF) | -- | -- | $81.9M | $82.1M | $63.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $81.9M | $182K | -$18.2M | -$28.1M | |
| Ending Cash (CF) | -- | $81.9M | $82.1M | $63.9M | $35.8M | |
| Levered Free Cash Flow | -- | -$56.9M | -$13.5M | -$95.1M | -$31.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$17.5M | -$38.5M | |
| Depreciation & Amoritzation | -- | -- | -- | $3.9M | $3.5M | |
| Stock-Based Compensation | -- | -- | -- | $515K | $2.8M | |
| Change in Accounts Receivable | -- | -- | -- | $15.4M | $117.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -$23.3M | $44.9M | |
| Capital Expenditures | -- | -- | -- | $902K | $514K | |
| Cash Acquisitions | -- | -- | -- | $8.8M | -$3M | |
| Cash From Investing | -- | -- | -- | $8.9M | -$3.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -$33.7M | -$32.5M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$296K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$5.7M | $446K | |
| Cash From Financing | -- | -- | -- | $15.2M | -$32.4M | |
| Beginning Cash (CF) | -- | -- | -- | $63.2M | $26.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $754K | $9.2M | |
| Ending Cash (CF) | -- | -- | -- | $63.9M | $35.8M | |
| Levered Free Cash Flow | -- | -- | -- | -$24.2M | $44.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$2.3M | -$124.7M | |
| Depreciation & Amoritzation | -- | -- | -- | $17.1M | $15.1M | |
| Stock-Based Compensation | -- | -- | -- | $2.1M | $6.1M | |
| Change in Accounts Receivable | -- | -- | -- | -$6.8M | $115.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$3.1M | -$88.1M | -$21.3M | |
| Capital Expenditures | -- | -- | -- | $7M | $10.5M | |
| Cash Acquisitions | -- | -- | -- | -$6.9M | -$6.3M | |
| Cash From Investing | -- | -- | -- | $22.1M | $15M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $9.5M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$6.8M | -$1.5M | |
| Cash From Financing | -- | -- | -- | $47.9M | -$21.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$18.2M | -$28.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$95.1M | -$31.7M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$2.3M | -$124.7M | -- | |
| Depreciation & Amoritzation | -- | -- | $17.1M | $15.1M | -- | |
| Stock-Based Compensation | -- | -- | $2.1M | $6.1M | -- | |
| Change in Accounts Receivable | -- | -- | -$6.8M | $115.3M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$88.1M | -$21.3M | -- | |
| Capital Expenditures | -- | -- | $7M | $10.5M | -- | |
| Cash Acquisitions | -- | -- | -$6.9M | -$6.3M | -- | |
| Cash From Investing | -- | -- | $22.1M | $15M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $9.5M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$29.9M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$6.8M | -$1.5M | -- | |
| Cash From Financing | -- | -- | $47.9M | -$21.9M | -- | |
| Beginning Cash (CF) | -- | -- | $284.9M | $141.6M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$18.2M | -$28.1M | -- | |
| Ending Cash (CF) | -- | -- | $266.7M | $113.5M | -- | |
| Levered Free Cash Flow | -- | -- | -$95.1M | -$31.7M | -- | |
Get SHIM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SHIM
Sector
P/E ratio
--
17.50x
PEG ratio
0.00x
0.28x
P/B ratio
49.86x
1.67x
Price / LTM sales
0.11x
0.90x
Growth Metrics
SHIM
Sector
Revenue growth
-25%
3.01%
Earnings growth
--
6.36%
Revenue (5-year growth)
--
4.39%
Earnings forecast
-$0.36
$0.36
Profitability
SHIM
Sector
Profitability FY 2024
-$55.6M
$412.5M
Return on invested capital
-246.15%
5.68%
Return on assets
-36.06%
3.57%
Return on equity
-827.87%
8.64%
Earnings Date
Last Earnings Date
Mar
13
Next Earnings Date
May
13
Estimated Next Earnings Date
Jun
12
Balance Sheet
SHIM
Sector
Total cash
$33.7M
$161.8M
Short term investments
--
$42.6M
Total assets
$233.9M
$1.9B
Long term debt
$9.5M
$267.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
